Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYVJRR92
Stock Name / FundiShares MSCI USA SRI UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerSUUS(GBX) LSE
ETF TickerQDVR(EUR) F
ETF TickerQDVR.DE(EUR) CXE
ETF TickerSUAS.LS(USD) CXE
ETF TickerSUASz(USD) CXE
ETF TickerSUAU.AS(EUR) CXE
ETF TickerSUAS(EUR) ETF Plus
ETF TickerSUAU(EUR) Euronext Amsterdam
ETF TickerSUUS.L(GBP) LSE

Holdings detail for AMGN

Stock NameAmgen Inc
TickerAMGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS0311621009
LEI62QBXGPJ34PQ72Z12S66

Show aggregate AMGN holdings

News associated with AMGN

AstraZeneca: CHMP Recommends Approval Of Tezspire In The EU
(RTTNews) - AstraZeneca and Amgen's Tezspire or tezepelumab has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps. The CHMP of the European Medicines Agency based its positive opinion on results f - 2025-09-22 03:19:15
Notable Friday Option Activity: AMGN, FTNT, NOW
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Amgen Inc (Symbol: AMGN), where a total of 16,898 contracts have traded so far, representing approximately 1.7 million underlying shares. That amounts to about 81.4% of A - 2025-09-19 14:45:06
Dow Movers: NKE, AAPL
In early trading on Friday, shares of Apple topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.4%. Year to date, Apple has lost about 3.6% of its value. And the worst performing Dow component thus far on the day is Nike, trading - 2025-09-19 11:32:51
Brokerages Set Amgen Inc. (NASDAQ:AMGN) Target Price at $304.43
Amgen Inc. (NASDAQ:AMGN – Get Free Report) has earned a consensus recommendation of “Hold” from the twenty-two brokerages that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation, seven have issued a buy recommendation and one has given a strong buy […] - 2025-09-16 03:06:59
Noteworthy ETF Inflows: SCHD, AMGN, TXN, LMT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab US Dividend Equity ETF (Symbol: SCHD) where we have detected an approximate $245.9 million dollar inflow -- that's a 0.3% increase week over w - 2025-09-15 11:54:07
Noteworthy ETF Inflows: SCHV, DIS, PEP, AMGN
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab U.S. Large-Cap Value ETF (Symbol: SCHV) where we have detected an approximate $209.8 million dollar inflow -- that's a 1.6% increase week over - 2025-09-05 11:52:00
UDOW, AMGN, IBM, MMM: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro Dow30 (Symbol: UDOW) where we have detected an approximate $189.7 million dollar outflow -- that's a 20.8% decrease week over wee - 2025-08-28 11:56:19
Dow Movers: JNJ, CRM
In early trading on Thursday, shares of Salesforce topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.0%. Year to date, Salesforce has lost about 24.4% of its value. And the worst performing Dow component thus far on the day is J - 2025-08-28 11:13:35
Piper Sandler Increases Amgen (NASDAQ:AMGN) Price Target to $342.00
Amgen (NASDAQ:AMGN – Get Free Report) had its price target hoisted by equities researchers at Piper Sandler from $328.00 to $342.00 in a research note issued on Monday, Marketbeat reports. The firm presently has an “overweight” rating on the medical research company’s stock. Piper Sandler’s price objective would suggest a potential upside of 18.10% from […] - 2025-08-27 02:08:56
Amgen: FDA Broadens Approved Use Of Repatha
(RTTNews) - Amgen (AMGN) announced the FDA has broadened the approved use of Repatha or evolocumab to include adults at increased risk for major adverse cardiovascular events due to uncontrolled low-density lipoprotein cholesterol. The update removes a prior requirement for a pat - 2025-08-25 10:38:20
Validea Detailed Fundamental Analysis - AMGN
Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to shareholders via - 2025-08-25 10:34:54
3 Dow Jones Dividend Stocks With Above-Average Yields You Can Buy Now and Hold for at Least a Decade
Key PointsUnitedHealth Group's reduced profit forecast for 2025 is disappointing, but the health insurance business is in a good position to bounce back. - 2025-08-20 06:21:00
Validea Detailed Fundamental Analysis - AMGN
Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to shareholders via - 2025-08-18 10:40:05
Dow Movers: AAPL, UNH
In early trading on Monday, shares of UnitedHealth Group topped the list of the day's best performing Dow Jones Industrial Average components, trading up 2.2%. Year to date, UnitedHealth Group has lost about 49.3% of its value. And the worst performing Dow component thus far o - 2025-08-11 12:44:47
Dow Movers: DIS, AAPL
In early trading on Wednesday, shares of Apple topped the list of the day's best performing Dow Jones Industrial Average components, trading up 2.7%. Year to date, Apple has lost about 16.8% of its value. And the worst performing Dow component thus far on the day is Walt Disne - 2025-08-06 11:13:00
Small-Caps Stay Higher, Other Indexes Dwindle
President Trump mentioned adding new tariffs on semiconductor imports, which helped move markets aside from the Russell 2000 lower. - 2025-08-05 19:02:00
After-Hours Earnings Report for August 5, 2025 : AMD, AMGN, ANET, AFL, CPNG, SU, SMCI, TOST, ALAB, DVN, IFF, EQH
The following companies are expected to report earnings after hours on 08/05/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Advanced Micro Devices, Inc. (AMD)is reporting for the quarter ending June 30, 2025. The computer company's consensus earn - 2025-08-05 15:00:01
Trade Deficit Narrowed More Than Expected
Trade Deficit Narrowed More Than Expected - 2025-08-05 12:03:00
Dow Movers: AMGN, AMZN
In early trading on Tuesday, shares of Amazon.com topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.8%. Year to date, Amazon.com has lost about 1.8% of its value. And the worst performing Dow component thus far on the day is Amg - 2025-08-05 11:21:09
Pre-markets Slightly Up on Mostly Good Q2 Earnings
Q2 earnings reports are overall posting favorable results, including this morning ahead of the open. - 2025-08-05 11:20:00
Selloff? What Selloff? Monday Market Rebound
Palantir is way up after reporting Q2 results Monday afternoon, while HIMS and VRTX are way off highs. - 2025-08-04 19:18:00
AMGN Named A Top Socially Responsible Dividend Stock
Amgen Inc (Symbol: AMGN) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a strong 3.2% yield, as well as being recognized by prominent asset managers as being a socially res - 2025-08-04 10:14:41
Amgen a Top 25 Dividend Giant With 3.21% Yield (AMGN)
Amgen Inc (Symbol: AMGN) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a stunning $32.91B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a strong 3.21% yield, according to the most recent Dividend Channel ''DividendRank' - 2025-08-04 10:14:38
Stocks Erase Early Gains as Chip Makers and Big Pharma Retreat
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.55%. September E-mini S&P futures (ESU25 ) fell -0.43%, and September E-mini Nasdaq futures (NQU25... - 2025-08-01 13:29:46
Stocks Erase Early Gains as Chip Makers and Big Pharma Retreat
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.55%. September E-mini S&P futures (ESU25 ) fell -0.43%, and September E-mini Nasdaq futures (NQU25... - 2025-08-01 12:09:41
Stocks Erase Early Gains as Chip Makers and Big Pharma Retreat
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.55%. September E-mini S&P futures (ESU25 ) fell -0.43%, and September E-mini Nasdaq futures (NQU25... - 2025-08-01 10:37:57
Stocks Erase Early Gains as Chip Makers and Big Pharma Retreat
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.55%. September E-mini S&P futures (ESU25 ) fell -0.43%, and September E-mini Nasdaq futures (NQU25... - 2025-08-01 09:47:14
Stocks Erase Early Gains as Chip Makers and Big Pharma Retreat
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.55%. September E-mini S&P futures (ESU25 ) fell -0.43%, and September E-mini Nasdaq futures (NQU25... - 2025-08-01 08:54:51
Stocks Erase Early Gains as Chip Makers and Big Pharma Retreat
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.55%. September E-mini S&P futures (ESU25 ) fell -0.43%, and September E-mini Nasdaq futures (NQU25... - 2025-08-01 08:41:33
Stocks Erase Early Gains as Chip Makers and Big Pharma Retreat
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.55%. September E-mini S&P futures (ESU25 ) fell -0.43%, and September E-mini Nasdaq futures (NQU25... - 2025-08-01 08:14:08

iShares MSCI USA SRI UCITS ETF USD (Acc) AMGN holdings

DateNumber of AMGN Shares HeldBase Market Value of AMGN SharesLocal Market Value of AMGN SharesChange in AMGN Shares HeldChange in AMGN Base ValueCurrent Price per AMGN Share HeldPrevious Price per AMGN Share Held
2025-10-01 (Wednesday)155,470USD 46,407,795USD 46,407,795
2025-09-30 (Tuesday)155,470USD 43,873,634AMGN holding increased by 1279518USD 43,873,6340USD 1,279,518 USD 282.2 USD 273.97
2025-09-29 (Monday)155,470USD 42,594,116AMGN holding increased by 153915USD 42,594,1160USD 153,915 USD 273.97 USD 272.98
2025-09-26 (Friday)155,470AMGN holding decreased by -226USD 42,440,201AMGN holding increased by 218560USD 42,440,201-226USD 218,560 USD 272.98 USD 271.18
2025-09-25 (Thursday)155,696USD 42,221,641AMGN holding decreased by -1251796USD 42,221,6410USD -1,251,796 USD 271.18 USD 279.22
2025-09-24 (Wednesday)155,696AMGN holding decreased by -241USD 43,473,437AMGN holding increased by 461334USD 43,473,437-241USD 461,334 USD 279.22 USD 275.83
2025-09-18 (Thursday)155,937AMGN holding decreased by -226USD 43,012,103AMGN holding increased by 112565USD 43,012,103-226USD 112,565 USD 275.83 USD 274.71
2025-09-17 (Wednesday)156,163USD 42,899,538AMGN holding increased by 253765USD 42,899,5380USD 253,765 USD 274.71 USD 273.085
2025-09-16 (Tuesday)156,163USD 42,645,773AMGN holding decreased by -205354USD 42,645,7730USD -205,354 USD 273.085 USD 274.4
2025-09-15 (Monday)156,163USD 42,851,127AMGN holding decreased by -310765USD 42,851,1270USD -310,765 USD 274.4 USD 276.39
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AMGN by Blackrock for IE00BYVJRR92

Show aggregate share trades of AMGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-26SELL-226 272.980* 292.34 Profit of 66,069 on sale
2025-09-24SELL-241 279.220* 292.53 Profit of 70,499 on sale
2025-09-18SELL-226 275.830* 292.62 Profit of 66,132 on sale
2025-09-10BUY216 278.510* 293.17
2025-09-08SELL-1,120 280.190* 293.32 Profit of 328,517 on sale
2025-08-29BUY682 287.710* 293.38
2025-08-27SELL-2,072 287.970* 293.42 Profit of 607,958 on sale
2025-08-06SELL-912 284.670* 293.50 Profit of 267,668 on sale
2025-08-04SELL-228 301.940* 293.40 Profit of 66,896 on sale
2025-07-31SELL-228 295.100* 293.37 Profit of 66,889 on sale
2025-07-30SELL-1,482 301.370* 293.32 Profit of 434,706 on sale
2025-07-29SELL-798 303.560* 293.26 Profit of 234,022 on sale
2025-07-28SELL-1,026 301.290* 293.21 Profit of 300,834 on sale
2025-07-18BUY109 294.760* 293.18
2025-07-17BUY1,110 298.250* 293.15
2025-07-16SELL-912 299.020* 293.11 Profit of 267,320 on sale
2025-07-15SELL-684 292.510* 293.12 Profit of 200,492 on sale
2025-07-11BUY452 295.270* 293.08
2025-07-10BUY678 300.370* 293.03
2025-07-09SELL-565 296.520* 293.01 Profit of 165,549 on sale
2025-07-08SELL-3,064 297.000* 292.98 Profit of 897,691 on sale
2025-06-27SELL-1,469 277.130* 293.09 Profit of 430,543 on sale
2025-06-26SELL-113 279.110* 293.18 Profit of 33,130 on sale
2025-06-24SELL-262 277.490* 293.39 Profit of 76,867 on sale
2025-06-20SELL-2,313 289.330* 293.57 Profit of 679,018 on sale
2025-06-17SELL-4,859 290.050* 293.65 Profit of 1,426,844 on sale
2025-06-13SELL-565 295.220* 293.62 Profit of 165,897 on sale
2025-06-12BUY545 297.290* 293.60
2025-06-09SELL-1,243 289.980* 293.64 Profit of 364,993 on sale
2025-06-06SELL-327 290.330* 293.66 Profit of 96,028 on sale
2025-06-04SELL-2,147 287.010* 293.77 Profit of 630,721 on sale
2025-06-03SELL-565 289.570* 293.80 Profit of 165,998 on sale
2025-06-02BUY753 288.470* 293.84
2025-05-30BUY6,077 288.180* 293.89
2025-05-27SELL-109 279.450* 294.22 Profit of 32,070 on sale
2025-05-23SELL-1,417 271.660* 294.60 Profit of 417,452 on sale
2025-05-21SELL-545 271.340* 295.00 Profit of 160,772 on sale
2025-05-19SELL-218 275.850* 295.34 Profit of 64,383 on sale
2025-05-16BUY996 272.410* 295.54
2025-05-15SELL-216 271.690* 295.75 Profit of 63,882 on sale
2025-05-14SELL-216 262.280* 296.05 Profit of 63,946 on sale
2025-05-13SELL-108 270.450* 296.28 Profit of 31,998 on sale
2025-05-12SELL-324 274.760* 296.47 Profit of 96,057 on sale
2025-05-09SELL-108 265.860* 296.75 Profit of 32,049 on sale
2025-05-08SELL-1,296 272.050* 296.98 Profit of 384,889 on sale
2025-05-01SELL-3 283.780* 297.89 Profit of 894 on sale
2025-04-30SELL-864 290.920* 297.96 Profit of 257,437 on sale
2025-04-28SELL-4,212 283.090* 298.20 Profit of 1,256,026 on sale
2025-04-25BUY540 280.840* 298.38
2025-04-23SELL-216 277.900* 298.78 Profit of 64,536 on sale
2025-04-17BUY108 277.290* 299.73
2025-04-14SELL-216 293.920* 300.03 Profit of 64,807 on sale
2025-04-11BUY691 285.980* 300.19
2025-04-10SELL-108 281.410* 300.41 Profit of 32,444 on sale
2025-04-09BUY324 291.090* 300.51
2025-04-08SELL-315 280.260* 300.75 Profit of 94,736 on sale
2025-04-07SELL-1,296 289.690* 300.88 Profit of 389,938 on sale
2025-04-04SELL-1,080 294.390* 300.96 Profit of 325,032 on sale
2025-04-02SELL-1,938 305.700* 300.90 Profit of 583,141 on sale
2025-03-31BUY395 311.550* 300.69
2025-03-28BUY216 306.950* 300.61
2025-03-27SELL-45 305.770* 300.55 Profit of 13,525 on sale
2025-03-26BUY324 305.710* 300.48
2025-03-25BUY540 306.860* 300.40
2025-03-21SELL-540 316.040* 300.01 Profit of 162,003 on sale
2025-03-20SELL-108 315.040* 299.80 Profit of 32,379 on sale
2025-03-19SELL-540 315.750* 299.58 Profit of 161,775 on sale
2025-03-18SELL-324 318.650* 299.32 Profit of 96,979 on sale
2025-03-14SELL-540 313.710* 298.86 Profit of 161,383 on sale
2025-03-13SELL-2,484 312.640* 298.66 Profit of 741,867 on sale
2025-03-12SELL-108 312.500* 298.45 Profit of 32,233 on sale
2025-03-11SELL-645 318.890* 298.15 Profit of 192,307 on sale
2025-03-07SELL-2,916 324.860* 297.29 Profit of 866,896 on sale
2025-03-05SELL-324 316.570* 296.99 Profit of 96,224 on sale
2025-03-03BUY1,080 310.780* 296.52
2025-02-28SELL-17,903 308.060* 296.33 Profit of 5,305,222 on sale
2025-02-27SELL-208 305.820* 296.17 Profit of 61,604 on sale
2025-02-26SELL-2,260 306.380* 296.00 Profit of 668,961 on sale
2025-02-25SELL-1,921 315.630* 295.66 Profit of 567,967 on sale
2025-02-21SELL-2,373 303.010* 295.28 Profit of 700,699 on sale
2025-02-20SELL-4,181 297.930* 295.23 Profit of 1,234,363 on sale
2025-02-19SELL-4,407 294.270* 295.25 Profit of 1,301,163 on sale
2025-02-13SELL-4,746 296.970* 295.43 Profit of 1,402,098 on sale
2025-02-12SELL-1,582 295.060* 295.43 Profit of 467,378 on sale
2025-02-11SELL-1,017 296.660* 295.41 Profit of 300,431 on sale
2025-02-10SELL-113 294.790* 295.42 Profit of 33,383 on sale
2025-02-07SELL-2,373 293.540* 295.46 Profit of 701,135 on sale
2025-02-06SELL-113 297.780* 295.41 Profit of 33,382 on sale
2025-02-05SELL-339 307.810* 295.13 Profit of 100,049 on sale
2025-02-04SELL-1,130 289.020* 295.27 Profit of 333,658 on sale
2025-02-03SELL-1,356 288.870* 295.42 Profit of 400,596 on sale
2025-01-29SELL-2,034 281.680* 296.33 Profit of 602,727 on sale
2025-01-28SELL-2,147 280.300* 296.75 Profit of 637,118 on sale
2025-01-24SELL-226 275.420* 297.72 Profit of 67,286 on sale
2025-01-23SELL-226 277.880* 298.29 Profit of 67,414 on sale
2025-01-02SELL-904 259.280* 299.44 Profit of 270,692 on sale
2024-12-10SELL-220 275.750* 300.16 Profit of 66,034 on sale
2024-12-09BUY678 277.630* 300.86
2024-12-04BUY113 278.260* 303.53
2024-12-02SELL-424 278.100* 305.40 Profit of 129,491 on sale
2024-11-29SELL-1,305 282.870* 306.27 Profit of 399,684 on sale
2024-11-27BUY342 280.070* 308.45
2024-11-26SELL-452 280.010* 309.69 Profit of 139,980 on sale
2024-11-25BUY1,758 294.000* 310.40
2024-11-22SELL-791 294.530* 311.16 Profit of 246,128 on sale
2024-11-21SELL-226 289.900* 312.22 Profit of 70,563 on sale
2024-11-19BUY565 279.950* 315.37
2024-11-18SELL-2,738 278.760* 317.52 Profit of 869,378 on sale
2024-11-12BUY226 298.840* 318.69
2024-11-07BUY2,034 321.910* 317.70
2024-11-05BUY1,695 319.290* 317.18
2024-11-04SELL-452 316.910* 317.21 Profit of 143,377 on sale
2024-11-01SELL-4,746 319.220* 316.98 Profit of 1,504,398 on sale
2024-10-31BUY1,008 320.160* 316.59
2024-10-30SELL-336 315.540* 316.73 Profit of 106,423 on sale
2024-10-29SELL-7,504 316.000* 316.86 Profit of 2,377,692 on sale
2024-10-28SELL-224 317.170* 316.79 Profit of 70,962 on sale
2024-10-25SELL-8,288 316.980* 316.75 Profit of 2,625,203 on sale
2024-10-24SELL-896 315.690* 317.10 Profit of 284,122 on sale
2024-10-23SELL-112 314.900* 318.20 Profit of 35,638 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AMGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19927,1851,9691,577,98658.8%
2025-09-18360,134369776,52846.4%
2025-09-17332,2321,017636,44352.2%
2025-09-16407,8469,423757,11553.9%
2025-09-15473,1033,717913,32551.8%
2025-09-12506,29927754,75867.1%
2025-09-11525,46824812,51064.7%
2025-09-10450,613101757,38359.5%
2025-09-09404,6071,059678,96459.6%
2025-09-08582,7331,546926,13062.9%
2025-09-05490,935359829,00759.2%
2025-09-04530,407391988,87253.6%
2025-09-03577,8444,861861,28967.1%
2025-09-02371,713741659,82756.3%
2025-08-29188,982404384,44749.2%
2025-08-28248,167128589,28842.1%
2025-08-27223,907652497,87845.0%
2025-08-26223,64776443,86850.4%
2025-08-25254,177133451,73756.3%
2025-08-22336,224576585,00357.5%
2025-08-21444,27051738,67960.1%
2025-08-20329,313159610,09754.0%
2025-08-19327,103918740,96044.1%
2025-08-18218,960166447,49748.9%
2025-08-15298,971280596,03450.2%
2025-08-14318,729208587,27954.3%
2025-08-13272,812853571,04147.8%
2025-08-12363,0961,521730,32949.7%
2025-08-11444,2491,334710,39562.5%
2025-08-08341,714554626,09454.6%
2025-08-07628,9491,999937,27667.1%
2025-08-061,550,0815791,952,92579.4%
2025-08-05718,7081,2151,035,72369.4%
2025-08-04461,049504708,32365.1%
2025-08-01414,3861,670977,07642.4%
2025-07-31454,423643738,06361.6%
2025-07-30311,065317518,97159.9%
2025-07-29348,397238556,40662.6%
2025-07-28340,948761620,79054.9%
2025-07-25337,980492537,16862.9%
2025-07-24371,751614548,55767.8%
2025-07-23347,6521,035635,91554.7%
2025-07-22649,0261,7451,075,12060.4%
2025-07-21481,2372,408754,15163.8%
2025-07-18316,168292518,57761.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.